31 – 40 of 100
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
The role of SRC family kinases in FLT3 signaling
- Contribution to journal › Scientific review
-
Mark
Glucocorticoid-resistant B cell acute lymphoblastic leukemia displays receptor tyrosine kinase activation
- Contribution to journal › Article
-
Mark
FMS-like Tyrosine Kinase 3/FLT3 : From Basic Science to Clinical Implications
- Contribution to journal › Article
-
Mark
Metallopeptidase inhibitor 1 (TIMP-1) promotes receptor tyrosine kinase c-Kit signaling in colorectal cancer
- Contribution to journal › Article
- 2018
-
Mark
SRC-like adaptor protein 2 (SLAP2) is a negative regulator of KIT-D816V-mediated oncogenic transformation
- Contribution to journal › Article
-
Mark
De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia
- Contribution to journal › Article
-
Mark
Bruton’s tyrosine kinase potentiates ALK signaling and serves as a potential therapeutic target of neuroblastoma
- Contribution to journal › Article
-
Mark
Acute leukemia cells resistant to PI3K/mTOR inhibition display upregulation of P2RY14 expression
- Contribution to journal › Letter
- 2017
-
Mark
The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL)
- Contribution to journal › Article
-
Mark
ABL2 suppresses FLT3-ITD-induced cell proliferation through negative regulation of AKT signaling
- Contribution to journal › Article
